In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CooperVision and Ocular Sciences: Stronger as One

Executive Summary

Economies of scale and product breadth were behind the $1.2 billion merger of contact lens companies the Cooper Companies and Ocular Sciences. The combined company will be better positioned to benefit from the three drivers in the rapidly growing $6 billion worldwide contact lens market: the bulge in the youth population known as Echo Boomers; an increasing mix of advanced, premium priced products, and the worldwide increase of myopia.

Topics

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV002402

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel